UT Southwestern faculty have discovered what appears to be an Achilles’ heel in ovarian cancers, as well as new biomarkers that could point to which patients are the best candidates for possible new treatments. The finding, published in the journal Cell, was made in part using a research tool invented in a UT Southwestern lab in the Cecil H. and […]
The Association for Molecular Pathology (AMP), the premier global, molecular diagnostic professional society, today released the preliminary results of its August 2020 SARS-CoV-2 Testing Survey for clinical laboratories. The anonymous survey was created and administered to monitor, understand, and collect real-time data on laboratories’ efforts and experiences during the COVID-19 pandemic response. Compared to the […]
Some highly effective medications also happen to be highly mysterious. Such is the case with the antidepressant drugs known as selective serotonin reuptake inhibitors, or SSRIs: They are the most common treatment for major depression and have been around for more than 40 years, yet scientists still do not know exactly how they work. Nor […]
Access to targeted therapies for lung cancer depends on accurate identification of patients’ biomarkers through molecular testing, but survey results published today in the Journal of Thoracic Oncology suggest that many international clinicians are unaware of evidence-based guidelines that support the use of molecular testing. Current evidence-based standards for molecular testing of lung cancer have […]
An active immune system plays an important role in stopping cancer progression by identifying tumor cells and targeting them for destruction. Any deviation in the normal activities of the immune system could lead to accelerated tumor growth. Moffitt Cancer Center researchers wanted to determine how myeloid cells, a type of immune cell, contribute to the […]
